Tags
Blog

'news' posts

Swedish Community Specialty Clinic’s impact profiled

The Swedish Community Specialty Clinic, which provides free specialized care for low-income patients, was recently profiled by the Catholic Health Association of the United States. The piece looks at the clinic’s impact on patient care and the savings it has generated by reducing unnecessary Emergency Department visits. Clinic Manager Tom Gibbons is quoted in the piece.

In February, Swedish was recognized for Outstanding Community Outreach by Seattle Business magazine, an award that cited the work of the Community Specialty Clinic, among other efforts.

In 2013, the Swedish Community Specialty Clinic received the Mission Leadership Award from Providence Health & Services. Swedish, a secular hospital system, is affiliated with Providence, a catholic health care ministry.

Seattle Times Guest Column: Why it’s worth signing up for insurance coverage by March 31

This week Tom Gibbon, Swedish Community Specialty Clinic Manager and co-chair the Cover King County Leadership Circle, co-authored a guest column in the Seattle Times encouraging readers to sign up for health insurance coverage before the March 31 deadline.


Read the Seattle Times column.

FDA declines approval of Lemtrada for the treatment of MS

On December 30, 2013, the US Food and Drug Administration declined to approve the use of alemtuzumab (Lemtrada) for the treatment of multiple sclerosis. The FDA stated that the manufacturer of Lemtrada “has not submitted evidence from adequate and well-controlled studies that demonstrate the benefits of Lemtrada outweigh its serious adverse effects.” This was a surprising decision to some, as only a month earlier an advisory panel of experts convened by the FDA, while raising some objections, voted to have this medicine approved. The manufacturer of Lemtrada, Genzyme, a Sanofi company, intends to appeal this decision.
 
In response, a number of MS organizations and experts have voiced their concerns that with this step, MS patients are left without a potential choice in therapy. This decision is particularly difficult for ...

Perspectives on Health Care

From the desk of Swedish Health Services Chief Executive Anthony (Tony) A. Armada, FACHE


Dear Friends of Swedish,

During the four months since I started as Swedish's Chief Executive, I have had the opportunity to meet and speak with many of you and to learn your thoughts about Swedish, and share mine.
I am writing today to reach out to those of you I have not yet met in person. So, until I get that chance, I want to introduce myself and share some of my thoughts about this great health system.
As I am sure you know, this is a unique and very challenging time in the health care industry. The financial and economic pressures we face are significant, and both the environment we work in and the rules we must follow are changing rapidly.

Nevertheless, I am pleased to report that Swedish has never been stronger. This is true from both a financial perspective and in terms of our ability to care for the patients and families who come to us for care. We are, in 2014, able to serve more patients, deliver more babies, provide more charity care for more individuals and families and see more visitors in our neighborhood clinics than ever before.

Swedish Honored at Leaders in Health Care 2014 Event

Seattle Business magazine recognizes Swedish for Outstanding Community Outreach

News Release
 
FOR IMMEDIATE RELEASE                                                                                        
 
Contacts: Clay Holtzman, Swedish, 206-386-2748, clay.holtzman@swedish.org
 
Swedish Honored at Leaders in Health Care 2014 Event
Seattle Business magazine recognizes Swedish for Outstanding Community Outreach
 
SEATTLE — Feb. 25, 2014 — Swedish Health Services’ Community Benefits Program received the Outstanding Community Outreach award at Seattle Business magazine’s fifth annual Leaders in Health Care awards celebration. The largest and most comprehensive non-profit health provider in the Pacific Northwest, Swedish is known for creating high-impact community outreach programs such as the Swedish Community Specialty Clinic and Global to Local (G2L).
 
The Leaders in Health Care awards honor 25 outstanding organizations in eight categories, ranging from medical research to lifetime achievement. The Outstanding Community Outreach award recognizes organizations that are committed to developing and implementing original programs that improve the health of local communities.  
 
“It is an honor to be recognized with such a prestigious award,” said Tom Gibbon, manager of the Swedish Community Specialty Clinic and Ballard High School Teen Clinic. “It showcases years of work that not only benefits the most vulnerable populations in our community, but also offers sustainable and replicable solutions that will change how care is delivered.”
 
The Swedish Community Benefits Program evaluates public health data and collaborates with local organizations to produce initiatives that address a wide range of community health needs in the Pacific Northwest. Since 2006, Swedish has launched more than 15 initiatives. Programs such as the Swedish Community Specialty Clinic and Global to Local exist to combat long-term challenges while addressing immediate health care needs.  
 

What you should know about multiple myeloma

Recent news about the health of the distinguished journalist, Tom Brokaw, has focused attention on multiple myeloma, a malignant disease of the bone marrow. Myeloma is characterized by an uncontrolled growth of marrow plasma cells, which normally produce antibodies for our immune system. In its advanced stages, the overgrowth of these cells and their associated proteins can cause anemia, painful bone destruction, and kidney failure.
 
Until about 10 years ago, advanced myeloma was uniformly fatal with a typical survival of about 3 years. Recent years, however, have seen a remarkable improvement in treatment possibilities for myeloma. This began with the discovery that autologous stem cell transplantation could produce complete remissions and longer survival. In addition, a variety of chemotherapy drugs administered in combination with corticosteroid drugs, now produce responses in up to 80% of patients. This means about 80% of patients are surviving longer than 3 years after chemotherapy and autologous stem cell transplant.
 
Not all patients with myeloma require chemotherapy. Myeloma can exist in an early stage for years. This is called smoldering myeloma. Chromosome analysis is routinely done on myeloma cells and allows us to identify patients with more aggressive forms of the disease, and those requiring treatment due to signs of organ damage or bone pain.
 
The Swedish Cancer Institute has been a participant in clinical trials leading to the development of some of the effective new treatments for myeloma. We are currently participating in a study of pomalidomide, a newly approved agent, for patients with relapsed myeloma. Another study offers an investigational drug, MLN9708, for newly diagnosed patients.
 
While the new drugs are more effective and better tolerated than previous chemotherapy, all  ...

Affordable Care Act Health Insurance Sign Up

Swedish/Issaquah is offering free, in-person assistance for anyone who wants to sign up for health insurance offered through the Affordable Care Act.  Those interested can attend the session between 10 a.m. and 6 p.m. on Monday, February 24 on the Swedish/Issaquah campus in the Knowledge Room located on the 2nd Floor, 751 N.E. Blakely Dr. Issaquah, WA 98029.

In person assisters will be on hand to help guide people through the registration process.

If you are interested but cannot attend, schedule an individual appointment by calling (206) 386-6996.
Results 8-14 of 100